CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
about
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsNatural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer.Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary diseaseStandardizing immunophenotyping for the Human Immunology Project.A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.OMIP-024: pan-leukocyte immunophenotypic characterization of PBMC subsets in human samples1α,25(OH)2 Vitamin D3 Modulates Avian T Lymphocyte Functions without Inducing CTL Unresponsiveness.Increased NK Cell Maturation in Patients with Acute Myeloid LeukemiaNK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation.Natural killer cell inhibitory receptor expression in humans and mice: a closer look.Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular SignaturesKiller Immunoglobulin-like Receptors (KIR) haplogroups A and B track with Natural Killer Cells and Cytokine Profile in Aged Subjects: Observations from Octo/Nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST).Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.The evolution of cellular deficiency in GATA2 mutationMaintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation.Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells.Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART.Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapyNatural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis.Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de GrTyrosine kinase 2 is not limiting human antiviral type III interferon responses.Human CD56bright NK Cells: An Update.TG4010: a vaccine with a therapeutic role in cancer.Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles.CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy.IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potentialNKG2D ligand expression in pediatric brain tumors.Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells.High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults.Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin.Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
P2860
Q26742158-169001F2-AB8C-4ADD-A263-27D7602117FDQ33734571-4007C35A-A897-4907-B255-C0E0F05A8D23Q33779221-8A091BC9-0219-471B-9FC5-BB82D2ADE406Q33810001-6D27BBD4-03CD-4441-8ABC-4DFD9B2C68BCQ33982284-9877E016-CAD5-4820-9A0E-6C087119AD1CQ34255224-E22A341C-1C68-4152-A22B-5EC7F69EC387Q34403480-40B8A3CE-BC2B-4CAE-860C-D2E597F92563Q34427488-CE477A59-9CFE-43A0-A2DD-A815C18D91E7Q34512559-C226ADC8-B272-45C6-B8F6-2A6B477B99A8Q35688250-C4E9BDE1-01EE-4270-B4AA-8B9B6E764E05Q35933893-191A34BE-4FDD-49ED-931A-F82D414395EFQ36256263-3513A8C0-A9C7-42C6-87B0-1FAE83EAEE90Q36310605-41BA75CB-C530-4BE2-8992-D7ABCFFF6312Q36715233-2CEFA6CE-6C5B-43D2-9627-9A7CDE78AADCQ36879291-AD499D88-A382-40B4-8699-6FF46B32FB81Q37308200-629012E6-9EFF-44FE-AA6B-9AC168757323Q37377103-980ABD89-6566-4276-8BB3-4136E2B22036Q37564769-07BC740F-BF8B-45AD-B2E0-295527D57D9CQ37564774-0791A196-F1AF-4F18-9F0E-300B19848335Q37620061-E0EA70A3-33A6-41FB-999E-CAF06B005657Q37634627-F816268C-E2D2-43CE-8F84-BCC4933D8D7CQ37634635-4888717B-D61D-469B-BAEA-50890ACA0F51Q37710781-1B97C9E8-FE43-4203-9C5A-8F925CB4A6F2Q38019320-647BC614-6C0E-4AE2-9E05-D00EEBA6C9B1Q38457805-761F4CC4-F90C-4E73-AF77-8B4AE27F1EDDQ38666661-7ED2635B-112B-46FA-A3C8-BD4435263814Q38733510-9C231E02-6AC5-4B22-8A39-F74D22496F75Q38781384-00CE1054-0148-4F1B-9FF2-7EB4157E97EBQ38824172-7EE25B4F-4C7C-4BD5-9D31-EC1E7D0DBAFFQ38876802-69C2BBF1-1DF7-4669-9010-16E51D90CB8DQ38998220-7C0CCF1A-87CE-472C-B74B-A6E290CB38BCQ39027063-5C558B81-4580-4E24-B81B-A5FC8194424FQ39196323-9712AB98-DA15-4262-9669-316219F0FF13Q39501862-27FF4D3E-6516-4315-A5D9-694D8F65C762Q40081116-D56FD492-7A53-4058-B7C6-F65D291C6D87Q40109884-F638AA38-CD36-40E7-8ECC-A081FFC4745EQ40735418-E9F8CE60-81B9-44B3-A9DA-C8A8F325E5E4Q40802998-E4952BF8-8E5C-4896-ADD9-4D5CBCF93EDFQ40965304-51FC1475-6759-4117-A214-10EB46EA1B2FQ41216074-451406D9-0A53-4C0C-B5B5-7E41ED8338C1
P2860
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@en
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@nl
type
label
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@en
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@nl
prefLabel
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@en
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@nl
P2093
P356
P1476
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
@en
P2093
Béhazine Combadière
Darragh Duffy
Julie Decocq
Patrice Debré
Stéphanie Nguyen Quoc
Vincent Vieillard
P304
P356
10.4049/JIMMUNOL.1100330
P407
P577
2011-05-09T00:00:00Z